Stockreport

KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

KALA BIO, Inc.  (KALA) 
Last kala bio, inc. earnings: 2/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.kalarx.com
PDF ARLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and [Read more]